adult atopic dermatitis
Conditions
Interventions
Trial group:Quality control indicators for the standardized diagnosis and treatment of moderate-to-severe atopic dermatitis in daily practice.
Control group:Conventional methods for diagnosis and treatment
Sponsors
Dematology Hospital of Southern Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Patients aged 18 to 65 years, of any gender, who voluntarily participate and sign the informed consent form. 2. Patients diagnosed with atopic dermatitis by a clinician, with a disease severity of moderate to severe (based on an Eczema Area and Severity Index (EASI) >7 or a validated Investigator Global Assessment (vIGA) score of >=3). 3. Patients who are willing and able to attend all study visits as per the protocol or investigator's recommendation. 4. Patients who are willing and able to complete the corresponding questionnaires at each visit. 5. Patients who are able to read, understand, and sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Currently participating or planning to participate in an interventional clinical trial. 2. Patients who are unable to independently complete electronic questionnaires using a smartphone or other electronic devices. 3. Patients deemed by the investigator to have other conditions that make them unsuitable for inclusion.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Eczema area and severity index (EASI); | — |
Secondary
| Measure | Time frame |
|---|---|
| validated investigator global assessment (vIGA);Patient-Oriented Eczema Measure (POEM);Dermatology Life Quality Index (DLQI);Atopic Dermatitis Control Tool;Peak Pruritus Numerical Rating Scale (pp-NRS); | — |
Countries
China
Contacts
Public ContactBin Yang
Dematology Hospital of Southern Medical University
Outcome results
None listed